Brief outline of the case
The candidate sat all papers ABCD in 2024.
Only the marks received in paper A, 42, were such that the Examination Board had decided the candidate did not pass the EQE 2024.
The candidate appealed this decision.
The DBA decided to set the decision under appeal aside,
CASELAW-EPO - reviews of EPO Boards of Appeal decisions
T 1841/23 – When The EPO decides to revoke a patent before the UPC has decided on infringement
The present blogpost is a new version of the post of 27.01.2025 after publication of the corresponding decision. When the post was originally drafted, only the minutes of the OP before the board were known.
EP 2 387 844 B1 relates to managing associated sessions in a network.
Its proprietor is KPN.
T 1865/22 - Deterioration of the technical effect compared to the closest prior art
EP 3 374 443 B1 relates to a non-aqueous stripping composition and to a method of stripping an organic coating from a substrate using this stripping composition.
Brief outline of the case
The patent was maintained according to a new MR filed in reply to the opposition.
The opponent appealed.
EP 2 387 844 B1 – When The EPO decides to revoke a patent before the UPC has decided on infringement
EP 2 387 844 B1 relates to managing associated sessions in a network.
Its proprietor is KPN.
Brief outline of the procedure before the EPO
An opposition was filed by Xiaomi and the OD decided maintenance in amended form. The opponent appealed the decision.
The UPC informed the board that EP 2 387 844 B1 was subjected to infringement proceedings before it.
T 295/22 – Is the mode of administration of a substance limiting or not for a second medical use
EP 2 962 690 B1 is a 2d generation divisional and relates to (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline1,3-dione, or a pharmaceutically acceptable polymorph, salt, solvate or hydrate thereof, and to the (+) enantiomer for use as a medicament.
Brief outline of the case
The patent was maintained according to AR3.
The proprietor and opponents 1-8 and 11-14,